Concepedia

Serum Paraoxonase/Arylesterase Activity Affects Outcome in Ischemic Stroke Patients

S. Michalak, Radosław Kaźmierski, Agnieszka Hellmann, Ewa Wysocka, Dagmara Kocialkowska-Adamczewska, Agnieszka Wencel-Warot, Wiesław L. Nowinski

Cerebrovascular Diseases · 2011 · 26 citations · 38 references

DOI

Abstract

The PON/ARE ratio is an important predictor of ischemic stroke outcome and can be used in clinical practice rather than evaluating either PON or ARE activity alone.

References

38

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Harold P. Adams, Birgitte H. Bendixen, L. Jaap Kappelle et al. · Stroke · 1993 · 12K citations · Full text

Classification and natural history of clinically identifiable subtypes of cerebral infarction

John Bamford, Peter Sandercock, Martin Dennis et al. · The Lancet · 1991 · 3.3K citations

, , +18

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.

A. D. Watson, J A Berliner, Susan Hama et al. · Journal of Clinical Investigation · 1995 · 1.2K citations · Full text

, , +17

Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.

Michael Aviram, Mira Rosenblat, C L Bisgaier et al. · Journal of Clinical Investigation · 1998 · 1.1K citations · Full text

, , +15

Serum esterases. 1. Two types of esterase (A and B) hydrolysing <i>p</i>-nitrophenyl acetate, propionate and butyrate, and a method for their determination

W. N. Aldridge · Biochemical Journal · 1953 · 740 citations · Full text

, , +8